Odyssean »

Arcus Biosciences Incorporated shares owned by Odyssean

Quarter-by-quarter ownership of Arcus Biosciences Incorporated (RCUS) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Arcus Biosciences Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Arcus Biosciences Incorporated held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcus Biosciences Incorporated by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.6M 86k 30.83

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Arcus Biosciences Incorporated

Gilead Sciences
BlackRock
Wellington Management Company
State Street Corporation
Suvretta Capital Management
Vanguard Portfolio Management
Vanguard Capital Management
Woodline Partners
Citadel Advisors
Siren
Geode Capital Management
Fisher Investments
Marshall Wace
Samlyn Capital
Bnp Paribas Investment Partners

View all funds holding Arcus Biosciences Incorporated